Oxidative stress biomarkers don't always signal diabetes risk

August 7, 2017
Credit: Georgia State University

High levels of compounds found in the body that are commonly associated with oxidative damage may actually be a good sign for some people, according to a recent review of multiple human studies led by an epidemiologist at the School of Public Health at Georgia State University.

Compounds known as F2-isoprostanes are conventionally interpreted as indicators or "biomarkers" of harmful oxidative stress detectable in human tissues and bodily fluids, researchers stated. These molecules are footprints of highly reactive free radicals, which are mainly formed in normal processes of energy metabolism.

"It has been hypothesized that elevated F2-isoprostane levels—as biomarkers of oxidative stress—will predict increased risk of type 2 ," the researchers said. But the hypothesis didn't hold true when the risk of diabetes was examined in a multi-ethnic study group. The study found that elevated levels of F2-isoprostanes are associated with a reduced risk of diabetes. Researchers explained their results by connecting elevated F2-isoprostane levels to the intensity of energy metabolism, which is known to be protective against and type 2 diabetes. The study also discovered racial differences in F2-isoprostanes.

While African-Americans are at increased risk of developing obesity and type 2 diabetes, they generally have lower levels of F2-isoprostanes, the researchers noted in their review. They also noted a study conducted among Atlanta's West African Immigrants, African Americans, and non-Hispanic Whites, which clearly demonstrated that African ancestry is associated with lower F2-isoprostane levels.

The researchers also analyzed studies that pointed to an association between increased F2-isoprostane levels and physical exercise—an intervention against developing obesity and type 2 diabetes.

"As African Americans show lower systemic levels of F2-isoprostanes, using these non-invasive biomarkers can enable the development of pharmacological and/or life style interventions targeted to the reduction of metabolic risks among African Americans," the researchers said.

Their review summarized 132 publications focused on in predisposition to obesity and type 2 diabetes in the United States and global research on F2-isoprostanes and human health; these studies ranged from socioeconomic and environmental factors determining racial disparities to human molecular studies on F2-isoprostanes.

The researchers' findings are published in Diversity and Equality in Health and Care in the review article "Systemic F2-Isopropstane Levels in Predisposition to Obesity and Type 2 Diabetes: Emphasis on Racial Differences." The article's lead author is Dr. Dora Il'yasova, associate professor of epidemiology and biostatistics at Georgia State.

Explore further: Aspirin enhances platelet isoprostanes in type 2 diabetes

More information: SystemicF2-Isoprostane Levels in Predisposition to Obesity and Type 2 Diabetes: Emphasis on Racial Differences. Diversity and Equality in Health and Care. diversityhealthcare.imedpub.co … fferences-18823.html

Related Stories

Aspirin enhances platelet isoprostanes in type 2 diabetes

March 23, 2012
(HealthDay) -- For patients with type 2 diabetes mellitus (T2DM) who are treated with aspirin, isoprostanes are overproduced, which is linked with enhanced platelet recruitment, according to a study published online March ...

Non-traditional risk factors illuminate racial disparities in type 2 diabetes

February 6, 2014
(Medical Xpress)—Two surprising risk factors – diminished lung function and low serum potassium levels - appear to have nearly the same impact as obesity in explaining why African-Americans are disproportionately prone ...

Race ranks higher than pounds in diabetes, heart-health risks

April 3, 2017
Americans of South Asian descent are twice as likely as whites to have risks for heart disease, stroke and diabetes, when their weight is in the normal range, according to a study headed by Emory University and UC San Francisco.

Link between racial discrimination and stress described in new study

September 14, 2011
The consequences of psychological stress, resulting from racial discrimination, may contribute to racial health disparities in conditions such as cardiovascular disease, diabetes and other age-associated diseases. This is ...

Serum trypsinogen levels down in type 1 diabetes

January 26, 2017
(HealthDay)—Patients with type 1 diabetes have significantly lower serum trypsinogen levels than those without type 1 diabetes, according to a study published online Jan. 23 in Diabetes Care.

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.